StockGlow

CRISPR Therapeutics AG (CRSPN.MX)

CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.

811.08+0.00%Healthcare
Compare CRSPN.MX with
StockGlow Score
4
Bearish
BearishBullish
1 year ago-23.7%

The outlook

CRISPR Therapeutics AG currently reads as bearish based on below its 50- & 200-day averages, 2% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range2% of the way from its 52-week low to high
Market cap
$79.88B
52-wk high
1,378.00
52-wk low
802.00
50-day avg
903.22
200-day avg
955.15
Trailing P/E
—

Similar stocks

0VRQ.LCRISPR Therapeutics AG$47.80-0.42%ROKU.MXRoku, Inc.$2,537.00+0.00%NION.MXNIO Inc.$83.99-0.12%AMD.MXAdvanced Micro Devices, Inc.$8,432.10-0.13%TDOC.MXTeladoc Health, Inc.$116.00-27.85%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy